Alameda, United States
Magnetic Insight, Inc, founded in 2014 and headquartered in the United States, is spearheading advancements in molecular imaging with its innovative Magnetic Particle Imaging (MPI) technology. Positioned at the intersection of Biotechnology, Health Care, Life Sciences, and Medical Devices, the company has carved a niche in the imaging landscape.
MPI is a novel functional imaging modality akin to PET, SPECT, and optical imaging. It enables real-time monitoring of biological events and offers unique capabilities, such as targeting biomarkers and supporting vascular imaging, with unmatched sensitivity and resolution. This is achieved through the use of iron oxide nanoparticles, allowing for direct and specific quantitation without interference from tissue depth.
Recently, Magnetic Insight secured a $3.00M grant investment from the University of California Berkeley on April 11, 2024, underscoring investor confidence in its potential to revolutionize clinical and research imaging capabilities. The company’s focus on advancing molecular imaging presents significant investment opportunities, especially for stakeholders aiming to transform healthcare diagnostics and therapeutics.
